Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease.

Ondo WG, Kenney C, Sullivan K, Davidson A, Hunter C, Jahan I, McCombs A, Miller A, Zesiewicz TA.

Neurology. 2012 May 22;78(21):1650-4. doi: 10.1212/WNL.0b013e3182574f28. Epub 2012 May 9.

PMID:
22573627
2.

Lubiprostone: chloride channel activator for chronic constipation.

Rivkin A, Chagan L.

Clin Ther. 2006 Dec;28(12):2008-21. Review.

PMID:
17296458
3.

Lubiprostone: a chloride channel activator for treatment of chronic constipation.

Ambizas EM, Ginzburg R.

Ann Pharmacother. 2007 Jun;41(6):957-64. Epub 2007 May 22. Review.

PMID:
17519292
4.

Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.

Lacy BE, Chey WD.

Expert Opin Pharmacother. 2009 Jan;10(1):143-52. doi: 10.1517/14656560802631319 . Review.

PMID:
19236188
5.

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly.

Gras-Miralles B, Cremonini F.

Clin Interv Aging. 2013;8:191-200. doi: 10.2147/CIA.S30729. Epub 2013 Feb 15. Review.

6.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
7.

Lubiprostone: a new drug for the treatment of chronic idiopathic constipation.

Baker DE.

Rev Gastroenterol Disord. 2007 Fall;7(4):214-22. Review.

PMID:
18192957
8.

Lubiprostone: in constipation-predominant irritable bowel syndrome.

Carter NJ, Scott LJ.

Drugs. 2009 Jun 18;69(9):1229-37. doi: 10.2165/00003495-200969090-00007. Review.

PMID:
19537839
9.

Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation.

Crowell MD, Harris LA, DiBaise JK, Olden KW.

Curr Opin Investig Drugs. 2007 Jan;8(1):66-70. Review.

PMID:
17263187
10.

Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.

Owen RT.

Drugs Today (Barc). 2008 Sep;44(9):645-52. doi: 10.1358/dot.2008.44.9.1269852. Review.

PMID:
19137119
11.

Management of constipation in Parkinson's disease.

Rossi M, Merello M, Perez-Lloret S.

Expert Opin Pharmacother. 2015 Mar;16(4):547-57. doi: 10.1517/14656566.2015.997211. Epub 2014 Dec 25. Review.

PMID:
25539892
12.

Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.

Chamberlain SM, Rao SS.

Expert Opin Drug Saf. 2012 Sep;11(5):841-50. doi: 10.1517/14740338.2012.708732. Epub 2012 Jul 27. Review.

PMID:
22834474
13.

Lubiprostone: a novel treatment for chronic constipation.

Lacy BE, Levy LC.

Clin Interv Aging. 2008;3(2):357-64. Review.

14.

Lubiprostone: a chloride channel activator.

Lacy BE, Levy LC.

J Clin Gastroenterol. 2007 Apr;41(4):345-51. Review.

PMID:
17413599
15.

Lubiprostone.

Winpenny JP.

IDrugs. 2005 May;8(5):416-22. Review.

PMID:
15883925
16.

Lubiprostone for Chronic Constipation.

Lacy BE.

Gastroenterol Hepatol (N Y). 2006 Jul;2(7):483. Review. No abstract available.

Supplemental Content

Support Center